Canada markets open in 2 hours 1 minute
  • S&P/TSX

    19,578.30
    -90.87 (-0.46%)
     
  • S&P 500

    4,122.47
    -17.59 (-0.42%)
     
  • DOW

    32,774.41
    -58.13 (-0.18%)
     
  • CAD/USD

    0.7767
    +0.0005 (+0.07%)
     
  • CRUDE OIL

    88.89
    -1.61 (-1.78%)
     
  • BTC-CAD

    29,787.49
    -509.42 (-1.68%)
     
  • CMC Crypto 200

    538.33
    -19.02 (-3.41%)
     
  • GOLD FUTURES

    1,805.80
    -6.50 (-0.36%)
     
  • RUSSELL 2000

    1,912.89
    -28.31 (-1.46%)
     
  • 10-Yr Bond

    2.7970
    0.0000 (0.00%)
     
  • NASDAQ futures

    13,071.00
    +39.50 (+0.30%)
     
  • VOLATILITY

    22.26
    +0.97 (+4.56%)
     
  • FTSE

    7,490.89
    +2.74 (+0.04%)
     
  • NIKKEI 225

    27,819.33
    -180.63 (-0.65%)
     
  • CAD/EUR

    0.7579
    -0.0016 (-0.21%)
     

Gilead Statement on U.S. Supreme Court Overturning Roe v. Wade

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

FOSTER CITY, Calif. --News Direct-- Gilead Sciences

FOSTER CITY, Calif., June 29, 2022 /3BL Media/ - The U.S. Supreme Court delivered a decision in Dobbs v. Jackson Women’s Health Organization, which overturned the landmark 1973 Roe v. Wade ruling. This decision will have significant implications for women’s healthcare in roughly half of the states across the country – states where many of our colleagues, partner organizations and patients live and work. Improving health equity has always been core to our mission, including removing barriers faced by women, transgender individuals and other groups who are disproportionately impacted. This focus has always transcended our innovative medicines. As a healthcare organization, we understand medical decisions are deeply personal, and we believe they should be made by individuals with advice from their physicians.

As a company, our goal is to ensure our employees and their dependents have access to the medical services they need, when they need them. We have ensured our medical plan covers reimbursement of travel and lodging expenses to cover employees who need to travel out of state in the U.S. to receive medical care related to women’s reproductive health services.

In addition, the Gilead Foundation will donate $1.5 million in support of organizations focused on reproductive health services. We have also initiated a special matching donation program where the Gilead Foundation will double any contributions made by individual employees up to the limit of $15,000.

Originally published by Gilead Sciences

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com

View source version on newsdirect.com: https://newsdirect.com/news/gilead-statement-on-u-s-supreme-court-overturning-roe-v-wade-229760843

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting